TLR8 agonist 2
Modify Date: 2025-08-21 15:54:12
TLR8 agonist 2 structure
|
Common Name | TLR8 agonist 2 | ||
|---|---|---|---|---|
| CAS Number | 2412937-64-3 | Molecular Weight | 326.40 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H22N8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TLR8 agonist 2TLR8 agonist 2 is a potent and selective TLR8 agonist with an EC50 of 3 nM for human TLR8. TLR8 agonist 2 shows less active against human TLR7 (EC50 of 33.33 μM)[1]. |
| Name | TLR8 agonist 2 |
|---|
| Description | TLR8 agonist 2 is a potent and selective TLR8 agonist with an EC50 of 3 nM for human TLR8. TLR8 agonist 2 shows less active against human TLR7 (EC50 of 33.33 μM)[1]. |
|---|---|
| Related Catalog | |
| Target |
TLR8:3 nM (EC50) TLR7:33.33 μM (EC50) |
| In Vitro | TLR8 agonist 2 (Example 1) increases the levels of TNF-α, IL-12p40, IFN-γ, and IFN-α with EC50 values 105 nM, 26 nM, 29 nM, and 2800 nM, respectively, in human peripheral blood mononuclear cells (hPBMC)[1]. |
| In Vivo | The pharmacokinetic related parameters of TLR8 agonist 2 (Example 1) in mice administered with the intravenous administration of 1 mg/kg and the oral administration of 5 mg/kg are detected. The T1/2 of TLR8 agonist 2 are 0.25 h (1 mg/kg i.v.) and 0.5 h (5 mg/kg p.o.), the AUClast are 450 ng/mL*hr (i.v.) and 624 ng/mL*hr (p.o.). And for oral administration, the bioavailability (%F) is 27.7%[1] |
| References |
| Molecular Formula | C16H22N8 |
|---|---|
| Molecular Weight | 326.40 |